BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19967383)

  • 1. The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment.
    Dalir Abdolahinia E; Han X
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma.
    Guan J; Liu X; Wang K; Jia Y; Yang B
    Open Med (Wars); 2022; 17(1):1682-1698. PubMed ID: 36349193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte programming by cancer therapy.
    Patysheva M; Frolova A; Larionova I; Afanas'ev S; Tarasova A; Cherdyntseva N; Kzhyshkowska J
    Front Immunol; 2022; 13():994319. PubMed ID: 36341366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling.
    Jawa Y; Yadav P; Gupta S; Mathan SV; Pandey J; Saxena AK; Kateriya S; Tiku AB; Mondal N; Bhattacharya J; Ahmad S; Chaturvedi R; Tyagi RK; Tandon V; Singh RP
    Front Oncol; 2021; 11():676948. PubMed ID: 34490084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
    PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.
    Berinstein NL; Wolf GT; Naylor PH; Baltzer L; Egan JE; Brandwein HJ; Whiteside TL; Goldstein LC; El-Naggar A; Badoual C; Fridman WH; White JM; Hadden JW
    Cancer Immunol Immunother; 2012 Jun; 61(6):771-82. PubMed ID: 22057678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune suppression in head and neck cancers: a review.
    Duray A; Demoulin S; Hubert P; Delvenne P; Saussez S
    Clin Dev Immunol; 2010; 2010():701657. PubMed ID: 21437225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in squamous cell carcinoma of the head and neck.
    Wendt TG; Bank P
    Onkologie; 2002 Jun; 25(3):208-12. PubMed ID: 12119454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear phagocytes in head and neck squamous cell carcinoma.
    Kross KW; Heimdal JH; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):335-44. PubMed ID: 19967383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer?
    Ferlito A; Takes RP; Rinaldo A; Devaney KO
    Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):325-6. PubMed ID: 19823861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic factors in primary radiochemo-therapy in advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation].
    Dietz A
    Laryngorhinootologie; 2002 Jan; 81(1):63-4. PubMed ID: 11845405
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyfunctionality of CD4
    Doescher J; Jeske S; Weissinger SE; Brunner C; Laban S; Bölke E; Hoffmann TK; Whiteside TL; Schuler PJ
    Strahlenther Onkol; 2018 May; 194(5):392-402. PubMed ID: 29663037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck.
    D'Souza J; Clark J
    Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):99-105. PubMed ID: 21297477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
    Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
    BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.